JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
160 hedge funds and large institutions have $2.61B invested in Juno Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
20% more capital invested
Capital invested by funds: $2.17B → $2.61B (+$437M)
61% less call options, than puts
Call options by funds: $12.5M | Put options by funds: $31.9M
Holders
160
Holding in Top 10
4
Calls
$12.5M
Puts
$31.9M
Top Buyers
| 1 | +$90.9M | |
| 2 | +$52M | |
| 3 | +$12.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$9.31M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$9.62M | |
| 3 | -$5.45M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$4.44M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$4.4M |